中文AV

Acquisition Positions Leading Wound Care Provider for Care Setting Expansion and Accelerated Growth

NEW YORK 鈥� AUGUST 11, 2020 鈥� 中文AV (鈥淥EP鈥�), a middle market private equity firm, today announced that it has acquired American Medical Technologies (鈥淎MT鈥� or 鈥渢he Company鈥�), a provider of advanced wound care, ostomy, urology and tracheostomy supplies and services. Financial terms of the private transaction were not disclosed.

Founded in 1994, Irvine, California-based AMT provides both critical care supplies and clinical support services to skilled nursing facilities and other post-acute care settings across the United States. The Company assists healthcare providers with managing the treatment of more than 250,000 wounds annually.

鈥淎MT has an excellent reputation as a market-leader in advanced wound care and clinical care services that help accelerate wound healing, mitigate infection complications, reduce hospital re-admittance, and increase patient satisfaction while reducing costs for facilities,鈥� said Greg Belinfanti, Senior Managing Director, OEP. 鈥淲e look forward to supporting AMT鈥檚 leadership in pursuing a significant number of expansion opportunities to bring AMT into the next phase of its growth.鈥�

Serving more than 6,250 facilities across the U.S., AMT鈥檚 service model enables its customers to outsource billing, clinical programming, supply chain management and scheduling of wound care cases, and provides clinical staff with access to AMT鈥檚 comprehensive wound care expertise.

鈥淲e are thrilled to partner with OEP to expand our value-added services to Skilled Nursing Facilities,鈥� said Sam Muppalla, Chief Executive Officer, AMT. 鈥淚ncreased patient acuity and wound complexity are highlighting the need for outcome-focused wound management services. OEP shares our vision for providing patients with comprehensive care that improves quality of life and drives better outcomes.鈥�

鈥淭his transaction reflects OEP鈥檚 ability to source proprietary investment opportunities where we can leverage our experience in the post-acute healthcare sector,鈥� said Brad Coppens, Managing Director, OEP. 鈥淲e look forward to expanding AMT鈥檚 role in the healthcare delivery ecosystem to multiple additional care settings鈥攂oth organically and through acquisitions鈥攁s recent changes in post-acute reimbursement favor service providers like AMT that serve the needs of chronically-ill, medically-complex patients.鈥�

OEP has a long track record of partnering with management teams and founders of healthcare businesses to identify strategic growth opportunities and improve operational efficiencies. AMT will be the third investment from OEP鈥檚 Fund VII in the post-acute spectrum of care, following recent investments in Ernest Health, a market leader in inpatient rehabilitation facilities, and AdaptHealth Corp. (NASDAQ: AHCO), a leading provider of home medical equipment, supplies and related services.

About 中文AV
OEP is a middle market private equity firm focused on the industrial, healthcare, and technology sectors in North America and Europe. The firm builds market-leading companies by identifying and executing transformative business combinations. OEP is a trusted partner with a differentiated investment process, a broad and senior team, and an established track record generating long-term value for its partners. Since 2001, the firm has completed more than 180 transactions worldwide. OEP, founded in 2001, spun out of JP Morgan in 2015. The firm has offices in New York, Chicago, and Frankfurt. For more information, please visit .

About American Medical Technologies
Founded in 1994, AMT is a leading advanced wound care company that delivers comprehensive wound care, ostomy, urological, and tracheostomy programs to health care providers in the long-term care and post-acute environments. AMT is also an accredited supplier of Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (鈥淒MEPOS鈥�) as well as a participating Medicare Part B provider. AMT serves over 6,250 facilities across all 50 states to facilitate the delivery of high-quality patient care.

Press contact for 中文AV:
Kelly Holman
Stanton
646-502-3509
KHolman@StantonPRM.com